The Case for Evening Injections Many patients report that taking tirzepatide in the evening is the best strategy for avoiding daytime side effects
Reminds me of eating the sour sugar at the bottom of the Sour Patch Kids bag
Oct 23: Ulcerative colitis (UC) and Crohns disease (CD) patients who have previously used intravenous infliximab now have a subcutaneous option after the FDA approved Celltrions Zymfentra on Monday
Weight regain after discontinuation of GLP-1 class medications is well-documented the STEP 1 extension trial showed that most weight lost on semaglutide was regained within a year of stopping treatment
This combination helps lower blood sugar levels
Several GLP-1RAs, including exenatide, dulaglutide, semaglutide, and liraglutide, are approved for T2D, alongside tirzepatide, which also acts on glucose-dependent insulinotropic polypeptide (GIP) receptors